Tricuspid valve disease and cardiac implantable electronic devices

Martin Andreas; Haran Burri; Fabien Praz; Osama Soliman; Luigi Badano; Manuel Barreiro; João L. Cavalcante; Tom De Potter; Torsten Doenst; Kai Friedrichs; Jörg Hausleiter; Nicole Karam; Susheel Kodali; Azeem Latib; Eloi Marijon; Suneet Mittal; Georg Nickenig; Aldo Rinaldi; Piotr Rudzinski; Marco Russo; Christoph Starck; Ralph Stephan Von Bardeleben; Nina Wunderlich; Jose Luis Zamorano; Rebecca T. Hahn; Francesco Maisano; Christophe Leclercq

doi:10.1093/eurheartj/ehad783

Tricuspid valve disease and cardiac implantable electronic devices

Martin Andreas
, Haran Burri
, Fabien Praz
, Osama Soliman
, Luigi Badano
, Manuel Barreiro
, João L. Cavalcante
, Tom De Potter
, Torsten Doenst
, Kai Friedrichs
, Jörg Hausleiter
, Nicole Karam
, Susheel Kodali
, Azeem Latib
, Eloi Marijon
, Suneet Mittal
, Georg Nickenig
, Aldo Rinaldi
, Piotr Rudzinski
, Marco Russo

Christoph Starck, Ralph Stephan Von Bardeleben, Nina Wunderlich, Jose Luis Zamorano, Rebecca T. Hahn, Francesco Maisano, Christophe Leclercq

Medical University Vienna
Geneva University Hospitals
University Hospital of Psychiatry
Galway University Hospital
University of Milano-Bicocca
Universitàdegli Studi di Milano-IRCCS Istituto Auxologico Italiano
Hospital Universitario Álvaro Cunqueiro
Minneapolis Heart Institute
OLV Hospital
Jena University Hospital
Heart and Diabetes Center North Rine Westphalia
Ludwig-Maximilians-University Munich
Partner site Berlin
AP-HP
Columbia University Medical Center
Montefiore Medical Center
The Synder Comprehensive Center for Atrial Fibrillation
University Hospital Bonn
Guys and St Thomas' NHS Foundation Trust
National Institute of Cardiology
AO San Camillo Forlanini
Deutsches Herzzentrum Berlin
Johannes-Gutenberg University of Mainz
Asklepios Klinik Langen
Hospital Universitario Ramón y Cajal
IRCCS San Raffaele Scientific Institute
Université de Rennes

Research output: Contribution to a Journal (Peer & Non Peer) › Review article › peer-review

139 Citations (Scopus)

Abstract

The role of cardiac implantable electronic device (CIED)-related tricuspid regurgitation (TR) is increasingly recognized as an independent clinical entity. Hence, interventional TR treatment options continuously evolve, surgical risk assessment and peri-operative care improve the management of CIED-related TR, and the role of lead extraction is of high interest. Furthermore, novel surgical and interventional tricuspid valve treatment options are increasingly applied to patients suffering from TR associated with or related to CIEDs. This multidisciplinary review article developed with electrophysiologists, interventional cardiologists, imaging specialists, and cardiac surgeons aims to give an overview of the mechanisms of disease, diagnostics, and proposes treatment algorithms of patients suffering from TR associated with CIED lead(s) or leadless pacemakers.

Original language	English
Pages (from-to)	346-365
Number of pages	20
Journal	European Heart Journal
Volume	45
Issue number	5
DOIs	https://doi.org/10.1093/eurheartj/ehad783
Publication status	Published - 1 Feb 2024
Externally published	Yes

Keywords

Cardiac implantable electronic device
Lead related
Pacemaker
Tricuspid regurgitation

Access to Document

10.1093/eurheartj/ehad783

Cite this

Andreas, M., Burri, H., Praz, F., Soliman, O., Badano, L., Barreiro, M., Cavalcante, J. L., De Potter, T., Doenst, T., Friedrichs, K., Hausleiter, J., Karam, N., Kodali, S., Latib, A., Marijon, E., Mittal, S., Nickenig, G., Rinaldi, A., Rudzinski, P., ... Leclercq, C. (2024). Tricuspid valve disease and cardiac implantable electronic devices. European Heart Journal, 45(5), 346-365. https://doi.org/10.1093/eurheartj/ehad783

@article{76a7ba5891544abab35d66f610c54118,

title = "Tricuspid valve disease and cardiac implantable electronic devices",

abstract = "The role of cardiac implantable electronic device (CIED)-related tricuspid regurgitation (TR) is increasingly recognized as an independent clinical entity. Hence, interventional TR treatment options continuously evolve, surgical risk assessment and peri-operative care improve the management of CIED-related TR, and the role of lead extraction is of high interest. Furthermore, novel surgical and interventional tricuspid valve treatment options are increasingly applied to patients suffering from TR associated with or related to CIEDs. This multidisciplinary review article developed with electrophysiologists, interventional cardiologists, imaging specialists, and cardiac surgeons aims to give an overview of the mechanisms of disease, diagnostics, and proposes treatment algorithms of patients suffering from TR associated with CIED lead(s) or leadless pacemakers.",

keywords = "Cardiac implantable electronic device, Lead related, Pacemaker, Tricuspid regurgitation",

author = "Martin Andreas and Haran Burri and Fabien Praz and Osama Soliman and Luigi Badano and Manuel Barreiro and Cavalcante, \{Jo{\~a}o L.\} and \{De Potter\}, Tom and Torsten Doenst and Kai Friedrichs and J{\"o}rg Hausleiter and Nicole Karam and Susheel Kodali and Azeem Latib and Eloi Marijon and Suneet Mittal and Georg Nickenig and Aldo Rinaldi and Piotr Rudzinski and Marco Russo and Christoph Starck and \{Von Bardeleben\}, \{Ralph Stephan\} and Nina Wunderlich and Zamorano, \{Jose Luis\} and Hahn, \{Rebecca T.\} and Francesco Maisano and Christophe Leclercq",

note = "Publisher Copyright: {\textcopyright} 2023 The Author(s). Published by Oxford University Press on behalf of the European Society of Cardiology.",

year = "2024",

month = feb,

day = "1",

doi = "10.1093/eurheartj/ehad783",

language = "English",

volume = "45",

pages = "346--365",

journal = "European Heart Journal",

issn = "0195-668X",

publisher = "Oxford University Press",

number = "5",

}

Andreas, M, Burri, H, Praz, F, Soliman, O, Badano, L, Barreiro, M, Cavalcante, JL, De Potter, T, Doenst, T, Friedrichs, K, Hausleiter, J, Karam, N, Kodali, S, Latib, A, Marijon, E, Mittal, S, Nickenig, G, Rinaldi, A, Rudzinski, P, Russo, M, Starck, C, Von Bardeleben, RS, Wunderlich, N, Zamorano, JL, Hahn, RT, Maisano, F & Leclercq, C 2024, 'Tricuspid valve disease and cardiac implantable electronic devices', European Heart Journal, vol. 45, no. 5, pp. 346-365. https://doi.org/10.1093/eurheartj/ehad783

TY - JOUR

T1 - Tricuspid valve disease and cardiac implantable electronic devices

AU - Andreas, Martin

AU - Burri, Haran

AU - Praz, Fabien

AU - Soliman, Osama

AU - Badano, Luigi

AU - Barreiro, Manuel

AU - Cavalcante, João L.

AU - De Potter, Tom

AU - Doenst, Torsten

AU - Friedrichs, Kai

AU - Hausleiter, Jörg

AU - Karam, Nicole

AU - Kodali, Susheel

AU - Latib, Azeem

AU - Marijon, Eloi

AU - Mittal, Suneet

AU - Nickenig, Georg

AU - Rinaldi, Aldo

AU - Rudzinski, Piotr

AU - Russo, Marco

AU - Starck, Christoph

AU - Von Bardeleben, Ralph Stephan

AU - Wunderlich, Nina

AU - Zamorano, Jose Luis

AU - Hahn, Rebecca T.

AU - Maisano, Francesco

AU - Leclercq, Christophe

PY - 2024/2/1

Y1 - 2024/2/1

N2 - The role of cardiac implantable electronic device (CIED)-related tricuspid regurgitation (TR) is increasingly recognized as an independent clinical entity. Hence, interventional TR treatment options continuously evolve, surgical risk assessment and peri-operative care improve the management of CIED-related TR, and the role of lead extraction is of high interest. Furthermore, novel surgical and interventional tricuspid valve treatment options are increasingly applied to patients suffering from TR associated with or related to CIEDs. This multidisciplinary review article developed with electrophysiologists, interventional cardiologists, imaging specialists, and cardiac surgeons aims to give an overview of the mechanisms of disease, diagnostics, and proposes treatment algorithms of patients suffering from TR associated with CIED lead(s) or leadless pacemakers.

AB - The role of cardiac implantable electronic device (CIED)-related tricuspid regurgitation (TR) is increasingly recognized as an independent clinical entity. Hence, interventional TR treatment options continuously evolve, surgical risk assessment and peri-operative care improve the management of CIED-related TR, and the role of lead extraction is of high interest. Furthermore, novel surgical and interventional tricuspid valve treatment options are increasingly applied to patients suffering from TR associated with or related to CIEDs. This multidisciplinary review article developed with electrophysiologists, interventional cardiologists, imaging specialists, and cardiac surgeons aims to give an overview of the mechanisms of disease, diagnostics, and proposes treatment algorithms of patients suffering from TR associated with CIED lead(s) or leadless pacemakers.

KW - Cardiac implantable electronic device

KW - Lead related

KW - Pacemaker

KW - Tricuspid regurgitation

UR - https://www.scopus.com/pages/publications/85184148289

U2 - 10.1093/eurheartj/ehad783

DO - 10.1093/eurheartj/ehad783

M3 - Review article

SN - 0195-668X

VL - 45

SP - 346

EP - 365

JO - European Heart Journal

JF - European Heart Journal

IS - 5

ER -

Tricuspid valve disease and cardiac implantable electronic devices

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this